ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
4 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
226
|
75K
|
4
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
4 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
226
|
75K
|
4
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
2 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
226
|
75K
|
2
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Australian swab for RAT supply deal
|
|
mathowa
|
21 |
6.1K |
0 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
21
|
6.1K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Australian swab for RAT supply deal
|
|
mathowa
|
21 |
6.1K |
0 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
21
|
6.1K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
3 |
16/07/22 |
16/07/22 |
ASX - By Stock
|
226
|
75K
|
3
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
2 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
226
|
75K
|
2
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
2 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
226
|
75K
|
2
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
0 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
226
|
75K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
2 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
226
|
75K
|
2
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
3 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
226
|
75K
|
3
|
|
ASX - By Stock
|
RNO |
Re:
Surescreen RAT with rhinoswab
|
|
mathowa
|
8 |
2.6K |
3 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
8
|
2.6K
|
3
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
1 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
226
|
75K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
$1.5B Medical Manufacturing fund
|
|
mathowa
|
4 |
1.6K |
0 |
22/05/22 |
22/05/22 |
ASX - By Stock
|
4
|
1.6K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mathowa
|
20 |
6.0K |
1 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
20
|
6.0K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mathowa
|
20 |
6.0K |
1 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
20
|
6.0K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mathowa
|
20 |
6.0K |
1 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
20
|
6.0K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mathowa
|
20 |
6.0K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
20
|
6.0K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Change in substantial holding WG
|
|
mathowa
|
10 |
2.3K |
2 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
10
|
2.3K
|
2
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Change in substantial holding WG
|
|
mathowa
|
10 |
2.3K |
1 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
10
|
2.3K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Despatch of Retail Offer Booklet
|
|
mathowa
|
5 |
2.4K |
4 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
5
|
2.4K
|
4
|
|
ASX - By Stock
|
RNO |
Re:
Ann: BTNX Supply Agreement
|
|
mathowa
|
30 |
9.9K |
3 |
09/04/22 |
09/04/22 |
ASX - By Stock
|
30
|
9.9K
|
3
|
|
ASX - By Stock
|
RNO |
Re:
Ann: BTNX Supply Agreement
|
|
mathowa
|
30 |
9.9K |
4 |
09/04/22 |
09/04/22 |
ASX - By Stock
|
30
|
9.9K
|
4
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
0 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
226
|
75K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
1 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
226
|
75K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
2 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
226
|
75K
|
2
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
1 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
226
|
75K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
3 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
226
|
75K
|
3
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
0 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
226
|
75K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mathowa
|
79 |
15K |
3 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
79
|
15K
|
3
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mathowa
|
79 |
15K |
2 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
79
|
15K
|
2
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mathowa
|
79 |
15K |
0 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
79
|
15K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mathowa
|
79 |
15K |
5 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
79
|
15K
|
5
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Rhinoswab junior clinical trial results
|
|
mathowa
|
48 |
13K |
3 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
48
|
13K
|
3
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Rhinoswab junior clinical trial results
|
|
mathowa
|
48 |
13K |
2 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
48
|
13K
|
2
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
1 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
226
|
75K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
1 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
226
|
75K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
0 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
226
|
75K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
4 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
226
|
75K
|
4
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Rhinoswab clinical trial approved at St Vincent's Hospital
|
|
mathowa
|
27 |
7.7K |
3 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
27
|
7.7K
|
3
|
|
ASX - By Stock
|
ENV |
Re:
Ann: ENV secures additional funding to complete testwork
|
|
mathowa
|
1 |
1.3K |
1 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
1
|
1.3K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
0 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
226
|
75K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Banter and General comments RNO
|
|
mathowa
|
226 |
75K |
0 |
17/10/21 |
17/10/21 |
ASX - By Stock
|
226
|
75K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Rhinomed appoints Rhinoswab distributors - supplementary dis
|
|
mathowa
|
21 |
6.9K |
2 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
21
|
6.9K
|
2
|
|
ASX - By Stock
|
RNO |
Re:
Rhinomed mute
|
|
mathowa
|
54 |
14K |
4 |
26/09/21 |
26/09/21 |
ASX - By Stock
|
54
|
14K
|
4
|
|
ASX - By Stock
|
MYL |
Re:
What project next for MYL?
|
|
mathowa
|
67 |
24K |
3 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
67
|
24K
|
3
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Rhinomed appoints Rhinoswab distributors - supplementary dis
|
|
mathowa
|
21 |
6.9K |
7 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
21
|
6.9K
|
7
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Rhinomed appoints Rhinoswab distributors - supplementary dis
|
|
mathowa
|
21 |
6.9K |
4 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
21
|
6.9K
|
4
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Half Yearly Report and Accounts
|
|
mathowa
|
3 |
2.0K |
0 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
3
|
2.0K
|
0
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Half Yearly Report and Accounts
|
|
mathowa
|
3 |
2.0K |
0 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
3
|
2.0K
|
0
|
|